Unlock instant, AI-driven research and patent intelligence for your innovation.

Medicine composition for treating plasma cell mastitis

A technology of mastitis and composition, which is applied in the field of medicine, can solve the problems of unsatisfactory clinical treatment effect, easy recurrence, long-lasting fistula, etc.

Inactive Publication Date: 2014-12-03
王忠亮
View PDF1 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

The clinical treatment effect is often unsatisfactory and it is easy to relapse after treatment, forming a fistula that lasts for a long time. In some cases, simple mastectomy is finally selected, which brings great pain to the patient.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment

[0011] Embodiment Decoction of the present invention

[0012] Weigh 12 grams of safflower, 15 grams of Chuanxiong, 9 grams of myrrh, 10 grams of curcuma, 6 grams of peach blossom, 9 grams of schisandra, 6 grams of Eupatorium, 10 grams of afternoon vanilla, 6 grams of evening primrose, and 6 grams of golden cherry , 15 grams of water fern, 9 grams of Radix Isatidis, 15 grams of cauliflower, 10 grams of northern plum, 6 grams of acacia bark, 5 grams of orchid grass, 9 grams of vine and 7 grams of golden old plum leaves, crushed, and added 5000 Milliliter of water, heated and refluxed for 5 hours in a flask equipped with a condenser tube, then filtered to obtain filtrate 1 and filter residue 1, added 3000 milliliters of water to the filter residue 1, heated in a flask equipped with a condenser tube for 3 hours, filtered, and obtained Filtrate 2 and filter residue 2, combine the filtrate 1 and the filtrate 2, concentrate to 1000 ml, cool to room temperature, and obtain.

experiment example

[0014] normal information

[0015] From January 2013 to January 2014, a total of 60 patients with plasma cell mastitis were treated, all of whom were non-pregnant and non-lactating women, aged 18-59 years, with an average age of 36.1 years; the course of disease was 1 week to 2 years; 39 cases were newly diagnosed, 21 cases recurred; 20 cases manifested as lumps, 23 cases of abscess formation, 19 cases of persistent fistula formation, 5 cases of multiple fistula openings, 38 cases of inverted nipple deformity, 42 cases of nipple discharge, skin There were 13 cases of adhesion and 25 cases of axillary lymph node enlargement. Nipple discharge patients underwent cytological examination, no cancer cells were found, and the lumps were irregular, hard, and unclear. Fine-needle aspiration cytological examination was performed to confirm the diagnosis. All cases were diagnosed based on typical clinical manifestations, imaging examinations (mammography and B-ultrasound) or biopsy (dia...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to a medicine composition for treating plasma cell mastitis. The medicine composition is prepared from the following medicinal materials: flos carthami, ligusticum wallichii, myrrh, curcuma zedoary, peach blossom, ecristate corydalis herb, herba lycopi, stickyhair pearleverlasting herb, evening primrose and fructus rosae laevigatae. Clinical application and observation prove that the medicine composition for treating plasma cell mastitis has the advantages of good curative effect, quick response and no toxic or side effect, and the raw materials are low in cost and easily available.

Description

technical field [0001] The invention relates to the field of medicine, in particular to a pharmaceutical composition for treating plasma cell mastitis. Background technique [0002] Plasma cell mastitis is a non-infectious mammary gland inflammation, a chronic breast disease based on obvious dilation of the collecting duct at the areola, peritubercular fibrosis, and infiltration of a large number of inflammatory cells, especially plasma cells. It mainly occurs in young and middle-aged women who are not pregnant or breastfeeding, and the incidence rate accounts for about 4%-5% of benign breast diseases. The clinical treatment effect is often unsatisfactory and it is easy to relapse after treatment, forming a fistula that does not heal for a long time. In some cases, a simple mastectomy is finally selected, which brings great pain to the patient. Therefore, finding a method with less damage and better therapeutic effect is a hot spot in the current discussion of this disease....

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K36/9066A61P15/14
Inventor 不公告发明人
Owner 王忠亮